T1	Assertion 99 106	need to
E1	Assertion:T1 
A1	Assertion-Type-Value E1 hypothetical
T2	Drug 114 124	medication
E2	Drug:T2 
T3	And 125 128	and
E3	And:T3 
T4	Drug 143 162	dietary supplements
E4	Drug:T4 Name:T22
T5	Assertion 178 185	need to
E5	Assertion:T5 
A2	Assertion-Type-Value E5 hypothetical
T6	Negation 191 193	no
E6	Negation:T6 
T7	Condition 194 218	blood clotting disorders
E7	Condition:T7 Name:T23
T8	Or 219 221	or
E8	Or:T8 
T9	Condition 222 235	dyslipidaemia
E9	Condition:T9 Name:T24
T10	Condition 274 292	clotting disorders
E10	Condition:T10 Name:T25
T11	Condition 294 306	dyslipidemia
E11	Condition:T11 Name:T26
T12	Or 307 309	or
E12	Or:T12 
T13	Eq-Comparison 316 318	on
E13	Eq-Comparison:T13 Temporal-Period:T27
T14	Drug 319 329	medication
E14	Drug:T14 
T15	Drug 336 343	statins
E15	Drug:T15 Name:T28
T16	Or 345 347	or
E16	Or:T16 
T17	Other 348 353	other
E17	Other:T17 
T18	Drug 354 365	supplements
E18	Drug:T18 Name:T29
T19	Temporal-Connection 366 372	during
E19	Temporal-Connection:T19 
A3	Temporal-Connection-Type-Value E19 during
T20	Study 377 382	study
E20	Study:T20 
T21	Negation 391 399	excluded
E21	Negation:T21 
T22	Drug-Name 143 162	dietary supplements
T23	Condition-Name 194 218	blood clotting disorders
T24	Condition-Name 222 235	dyslipidaemia
T25	Condition-Name 274 292	clotting disorders
T26	Condition-Name 294 306	dyslipidemia
T27	Eq-Temporal-Period 316 318	on
A4	Eq-Temporal-Period-Value T27 present
T28	Drug-Name 336 343	statins
T29	Drug-Name 354 365	supplements
